Evidence map›Paper›PMID 40443385›Full record

ReviewLin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery2025

[Research progress on the mechanisms of resistance to cetuximab targeted therapy in head and neck squamous cell carcinoma].

Lulu Liu, Dan Luo, Wenqing Zhang, Zhenfeng Sun

Abstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lulu LiuDepartment of Otolaryngology Head and Neck surgery，Shanghai General Hospital，Shanghai Jiao Tong University School Of Medicine，Shanghai，200080，China.
Dan LuoDepartment of Otolaryngology Head and Neck surgery，Shanghai General Hospital，Shanghai Jiao Tong University School Of Medicine，Shanghai，200080，China.
Wenqing ZhangDepartment of Otolaryngology，Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.
Zhenfeng SunDepartment of Otolaryngology Head and Neck surgery，Shanghai General Hospital，Shanghai Jiao Tong University School Of Medicine，Shanghai，200080，China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CetuximabDrug Resistance, NeoplasmHead and Neck NeoplasmsAntineoplastic Agents, ImmunologicalEpithelial-Mesenchymal TransitionErbB ReceptorsHumansMolecular Targeted TherapySquamous Cell Carcinoma of Head and NeckTumor MicroenvironmentAntineoplastic Agents, ImmunologicalCetuximabEGFR protein, humanErbB Receptorscetuximabhead and neck squamous cell carcinomaresistance mechanismstargeted therapy

Identifiers

PMID40443385
PMCPMC12527652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.